Terms: = Kidney tumors AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD AND Treatment
25 results:
1. Married Status Affects Rates of treatment and Mortality in Male and Female Renal Cell Carcinoma Patients Across all Stages.
Siech C; Morra S; Scheipner L; Baudo A; Jannello LMI; de Angelis M; Goyal JA; Tian Z; Saad F; Shariat SF; Longo N; Carmignani L; de Cobelli O; Ahyai S; Briganti A; Mandel P; Kluth LA; Chun FKH; Karakiewicz PI
Clin Genitourin Cancer; 2024 Apr; 22(2):593-598. PubMed ID: 38369387
[TBL] [Abstract] [Full Text] [Related]
2. Laparoscopic Radical Nephrectomy with Transperitoneal Approach for Large Renal tumors: Standardized Surgical Technique and Outcomes.
Peltrini R; Iacone B; Pacella D; Ilardi M; Sannino D; Tedesco A; Gargiulo A; Martirani M; Bracale U; Corcione F
J Laparoendosc Adv Surg Tech A; 2023 Sep; 33(9):879-883. PubMed ID: 37262180
[No Abstract] [Full Text] [Related]
3. A retrospective single-centered, comprehensive targeted genetic sequencing analysis of prognostic survival using tissues from Korean patients with metastatic renal cell carcinoma after targeted therapy.
Kim SH; Park J; Park WS; Hong D; Chung J
Investig Clin Urol; 2022 Nov; 63(6):602-611. PubMed ID: 36347549
[TBL] [Abstract] [Full Text] [Related]
4. Interstitial Brachytherapy of the Liver for Renal Cell Carcinoma: ADC Measurements Do Not Predict Overall Survival.
Thormann M; Heitmann F; Wrobel V; March C; Pech M; Surov A; Damm R; Omari J
In Vivo; 2022; 36(6):2945-2951. PubMed ID: 36309358
[TBL] [Abstract] [Full Text] [Related]
5. Genomic Profiling and Response to Immune Checkpoint Inhibition plus Tyrosine Kinase Inhibition in FH-Deficient Renal Cell Carcinoma.
Xu Y; Kong W; Cao M; Wang J; Wang Z; Zheng L; Wu X; Cheng R; He W; Yang B; Dong B; Pan J; Chen Y; Huang J; Jiang C; Zhai W; Li F; Chen R; Zhou X; Wu G; Geng X; Chen J; An H; Yuan Y; Xu T; Chen D; Lin D; Xu L; Huang K; Peng L; Yu Y; Tai S; Qi H; Luo K; Kang X; Wang H; Huang Y; Zhang J; Xue W
Eur Urol; 2023 Feb; 83(2):163-172. PubMed ID: 35715365
[TBL] [Abstract] [Full Text] [Related]
6. Epigenetic inactivation of ACAT1 promotes epithelial-mesenchymal transition of clear cell renal cell carcinoma.
Han P; Wu S; Li L; Li D; Zhao J; Zhang H; Wang Y; Zhong X; Zhang Z; Li P; Matskova L; Zhou X
Genes Genomics; 2022 Apr; 44(4):487-497. PubMed ID: 34985712
[TBL] [Abstract] [Full Text] [Related]
7. Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features.
Kishan AU; Karnes RJ; Romero T; Wong JK; Motterle G; Tosoian JJ; Trock BJ; Klein EA; Stish BJ; Dess RT; Spratt DE; Pilar A; Reddy C; Levin-Epstein R; Wedde TB; Lilleby WA; Fiano R; Merrick GS; Stock RG; Demanes DJ; Moran BJ; Braccioforte M; Huland H; Tran PT; Martin S; Martínez-Monge R; Krauss DJ; Abu-Isa EI; Alam R; Schwen Z; Chang AJ; Pisansky TM; Choo R; Song DY; Greco S; Deville C; McNutt T; DeWeese TL; Ross AE; Ciezki JP; Boutros PC; Nickols NG; Bhat P; Shabsovich D; Juarez JE; Chong N; Kupelian PA; D'Amico AV; Rettig MB; Berlin A; Tward JD; Davis BJ; Reiter RE; Steinberg ML; Elashoff D; Horwitz EM; Tendulkar RD; Tilki D
JAMA Netw Open; 2021 Jul; 4(7):e2115312. PubMed ID: 34196715
[TBL] [Abstract] [Full Text] [Related]
8. Hereditary Diffuse Gastric Cancer Syndrome and the Role of cdh1: A Review.
Gamble LA; Heller T; Davis JL
JAMA Surg; 2021 Apr; 156(4):387-392. PubMed ID: 33404644
[TBL] [Abstract] [Full Text] [Related]
9. Metastatic renal cell carcinoma to the pancreas: Clinical features and treatment outcome.
Shin TJ; Song C; Jeong CW; Kwak C; Seo S; Kang M; Chung J; Hong SH; Hwang EC; Park JY; Lee H
J Surg Oncol; 2021 Jan; 123(1):204-213. PubMed ID: 33047324
[TBL] [Abstract] [Full Text] [Related]
10. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Correa RJM; Louie AV; Zaorsky NG; Lehrer EJ; Ellis R; Ponsky L; Kaplan I; Mahadevan A; Chu W; Swaminath A; Hannan R; Onishi H; Teh BS; Muacevic A; Lo SS; Staehler M; Siva S
Eur Urol Focus; 2019 Nov; 5(6):958-969. PubMed ID: 31248849
[TBL] [Abstract] [Full Text] [Related]
11. Nephron sparing surgery (NSS) for unilateral wilms tumor (UWT): the SIOP 2001 experience.
Wilde JC; Aronson DC; Sznajder B; Van Tinteren H; Powis M; Okoye B; Cecchetto G; Audry G; Fuchs J; Schweinitz DV; Heij H; Graf N; Bergeron C; Pritchard-Jones K; Van Den Heuvel-Eibrink M; Carli M; Oldenburger F; Sandstedt B; De Kraker J; Godzinski J
Pediatr Blood Cancer; 2014 Dec; 61(12):2175-9. PubMed ID: 25156758
[TBL] [Abstract] [Full Text] [Related]
12. Outcomes after photoselective vaporization of the prostate and transurethral resection of the prostate in patients who develop prostatic obstruction after radiation therapy.
Abelson B; Reddy CA; Ciezki JP; Angermeier K; Ulchaker J; Klein EA; Wood HM
Urology; 2014 Feb; 83(2):422-7. PubMed ID: 24315301
[TBL] [Abstract] [Full Text] [Related]
13. Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease course.
Ueno D; Yao M; Tateishi U; Minamimoto R; Makiyama K; Hayashi N; Sano F; Murakami T; Kishida T; Miura T; Kobayashi K; Noguchi S; Ikeda I; Ohgo Y; Inoue T; Kubota Y; Nakaigawa N
BMC Cancer; 2012 May; 12():162. PubMed ID: 22551397
[TBL] [Abstract] [Full Text] [Related]
14. cdh16/Ksp-cadherin is expressed in the developing thyroid gland and is strongly down-regulated in thyroid carcinomas.
Calì G; Gentile F; Mogavero S; Pallante P; Nitsch R; Ciancia G; Ferraro A; Fusco A; Nitsch L
Endocrinology; 2012 Jan; 153(1):522-34. PubMed ID: 22028439
[TBL] [Abstract] [Full Text] [Related]
15. [Current peritoneal dialysis compared with haemodialysis: medium-term survival analysis of incident dialysis patients in the Canary Islands in recent years].
Rufino JM; García C; Vega N; Macía M; Hernández D; Rodríguez A; Maceira B; Lorenzo V
Nefrologia; 2011; 31(2):174-84. PubMed ID: 21461011
[TBL] [Abstract] [Full Text] [Related]
16. Slit-Robo signaling induces malignant transformation through Hakai-mediated E-cadherin degradation during colorectal epithelial cell carcinogenesis.
Zhou WJ; Geng ZH; Chi S; Zhang W; Niu XF; Lan SJ; Ma L; Yang X; Wang LJ; Ding YQ; Geng JG
Cell Res; 2011 Apr; 21(4):609-26. PubMed ID: 21283129
[TBL] [Abstract] [Full Text] [Related]
17. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma.
Motzer RJ; Hutson TE; Tomczak P; Michaelson MD; Bukowski RM; Oudard S; Negrier S; Szczylik C; Pili R; Bjarnason GA; Garcia-del-Muro X; Sosman JA; Solska E; Wilding G; Thompson JA; Kim ST; Chen I; Huang X; Figlin RA
J Clin Oncol; 2009 Aug; 27(22):3584-90. PubMed ID: 19487381
[TBL] [Abstract] [Full Text] [Related]
18. Risk of hypertension and renal dysfunction with an angiogenesis inhibitor sunitinib: systematic review and meta-analysis.
Zhu X; Stergiopoulos K; Wu S
Acta Oncol; 2009; 48(1):9-17. PubMed ID: 18752081
[TBL] [Abstract] [Full Text] [Related]
19. Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma.
Morris MR; Gentle D; Abdulrahman M; Clarke N; Brown M; Kishida T; Yao M; Teh BT; Latif F; Maher ER
Br J Cancer; 2008 Jan; 98(2):496-501. PubMed ID: 18195710
[TBL] [Abstract] [Full Text] [Related]
20. [Aberrant methylation of tumor suppressor genes in renal cell carcinoma].
Zhang Q; Jin J; Tao Q
Ai Zheng; 2007 Nov; 26(11):1276-80. PubMed ID: 17991333
[TBL] [Abstract] [Full Text] [Related]
[Next]
